APEX1 and chronic myelogenous leukemia, BCR-ABL1 positive: The K562 human chronic myelogenous leukemia cell line shows higher activity of APE1 (Supplementary Table 2), and a slight increase in the removal of uracil and hypoxanthine, activities primarily conducted by UNG and MPG (Figure 5A–5C, Supplementary Table 2).